Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations

References

• Martin-MoralesASanchez-CruzJJSaenz de TejadaIRodriguez-VelaLJimenez-CruzJFBurgos-RodriguezRPrevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina StudyJ Urol200116656957511458070
   PubMed Web of Science ®Google Scholar
• McVaryKLower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiologyBJU Int200697232816507050
   PubMed Web of Science ®Google Scholar
• RosenRAltweinJBoylePLower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)Eur Urol20034463764914644114
   PubMed Web of Science ®Google Scholar
• RosenRCWeiJTAlthofSESeftelADPerelmanMAAssociation of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH registryUrology20097356256619167031
   PubMed Web of Science ®Google Scholar
• McVaryKFoleyKALongSRSanderSCurticeTGShahHIdentifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunctionCurr Med Res Opin20082477578418237458
   PubMed Web of Science ®Google Scholar
• AnderssonKEde GroatWCMcVaryKTTadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of actionNeurourol Urodyn201130329230121284024
   PubMed Web of Science ®Google Scholar
• CameronASunPLageMComorbid conditions in men with ED before and after ED diagnosis: a retrospective database studyInt J Impot Res20061837538116395325
   PubMed Web of Science ®Google Scholar
• McVaryKTRoehrbornCGAvinsALAmerican Urological Association guideline: management of benign prostatic hyperplasia (BPH) Revised2010 Available from: http://www.auanet.org/education/guidelines/benign-prostatic-hyperplasia.cfmAccessed October 20, 2013
   Google Scholar
• MontagueDKJarrowJPBroderickGAAmerican Urological Association guideline: the management of erectile dysfunction2005 Available from: https://www.auanet.org/education/guidelines/erectile-dysfunction.cfmAccessed December 8, 2015
   Google Scholar
• AnderssonKEChappleCRHöfnerKFuture drugs for the treatment of benign prostatic hyperplasiaWorld J Urol20021943644212022712
   PubMed Web of Science ®Google Scholar
• MulhallJPGuhringPParkerMHoppsCAssessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunctionJ Sex Med2006366266716839322
   PubMed Web of Science ®Google Scholar
• GravasSBachTBachmannAGuidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) European Association of Urology-Update32015 Available from: http://www.uroweb.org/guidelines/Accessed May 15, 2015
   Google Scholar
• GacciMSalviMSebastianelliAThe use of a single daily dose of tadalafil to treat the signs and symptoms of benign prostatic hyperplasia and erectile dysfunctionRes Rep Urol201359911124400241
   PubMedGoogle Scholar
• SinghDVMeteUKMandalAKSinghSKA comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaJ Sex Med20141118719624165272
   PubMed Web of Science ®Google Scholar
• GacciMCoronaGSalviMA systematic review and meta-analysis of the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasiaEur Urol201261994100322405510
   PubMed Web of Science ®Google Scholar
• OelkeMGiulianoFBayganiSKMelbyTSontagATreatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomized, placebo-controlled studyBJU Int201411456857524612148
   PubMed Web of Science ®Google Scholar
• OelkeMGiulianoFMironeVXuLCoxDViktrupLMonotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomized, parallel, placebo-controlled clinical trialEur Urol20126191792522297243
   PubMed Web of Science ®Google Scholar
• SeftelADde la RosetteJBirtJPorterVZarotskyVViktrupLCoexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological dataInt J Clin Pract201267324523082930
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
   PubMedGoogle Scholar
• QuanHLiBCourisCMFushimiKUpdating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countriesAm J Epidemiol201117367668221330339
   PubMed Web of Science ®Google Scholar
• BharmalMPayneKAtkinsonMJDesrosiersMPMoriskyDEGemmenEValidation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medicationsHealth Qual Life Outcomes200973619397800
   PubMed Web of Science ®Google Scholar
• AlthofSECortyEWLevineSBEDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunctionUrology19995379379910197859
   PubMed Web of Science ®Google Scholar
• CappelleriJCRosenRCThe Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experienceInt J Impot Res20051730731915875061
   PubMed Web of Science ®Google Scholar
• BarryMJFowlerFJJrO’LearyMPBruskewitzRCHoltgreweHLMebustWKMeasuring disease-specific health status in men with benign prostatic hyperplasiaMed Care199533AS145AS1557536866
   PubMed Web of Science ®Google Scholar
• RosenRCRileyAWagnerGOsterlohIHKirkpatrickJMishraAThe International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunctionUrology1997498228309187685
   PubMed Web of Science ®Google Scholar
• JenkinsCDStantonBANiemcrykSJRoseRMA scale for the estimation of sleep problems in clinical researchJ Clin Epidemiol1988413133213351539
   PubMed Web of Science ®Google Scholar
• KimuraMShimuraSKobayashiHProfiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns: data from the nationwide Japanese populationJ Sex Med2012961649165822513057
   PubMed Web of Science ®Google Scholar
• KaplanSASide effects of α-blocker use: retrograde ejaculationRev Urol200911Suppl 1S14S1820126607
   PubMedGoogle Scholar
• YanHZongHCuiYLiNZhangYThe efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysisJ Sex Med2014111539154524621088
   PubMed Web of Science ®Google Scholar
• MoralesAMCasillasMTurbiCPatients’ preference in the treatment of erectile dysfunction: a critical review of the literatureInt J Impot Res2011231821191396
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296121011558866
   PubMed Web of Science ®Google Scholar
• AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
   PubMedGoogle Scholar
• HelfandBTFoughtAManvarAMMcVaryKTDetermining the utility of recalled lower urinary tract symptomsUrology20107644244720346488
   PubMed Web of Science ®Google Scholar
• SaloniaAGallinaABrigantiARemembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomyJ Sex Med2008567768318194187
   PubMed Web of Science ®Google Scholar
• BarryMJFowlerFJJrO’LearyMPThe American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological AssociationJ Urol1992148154915571279218
   PubMed Web of Science ®Google Scholar